Prognostic Significance of Bromodeoxyuridine Labeling in Primary and Recurrent Glioblastoma Multiforme-Reference-Cited by-同舟云学术

Prognostic Significance of Bromodeoxyuridine Labeling in Primary and Recurrent Glioblastoma Multiforme

Author:

Ritter Ann M.¹,Sawaya Raymond²,Hess Kenneth R.³,Levin Victor A.⁴,Bruner Janet M.⁵

Affiliation:

1. Department of Neurosurgery, Baylor College of Medicine

2. Department of Neurosurgery, The University of Texas M.D. Anderson Cancer Center, Houston, Texas

3. Department of Neurosurgery Patient Studies, The University of Texas M.D. Anderson Cancer Center, Houston, Texas

4. Department of Neurosurgery Neuro-oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas

5. Department of Neurosurgery Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Clinical Neurology,Surgery

Link

Reference41 articles.

3. Biology of gliomas: Potential clinical implications of glioma cellular heterogeneity;Bigner;Neurosurgery,1981

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Glioblastoma;Russell & Rubinstein's Pathology of Tumors of the Nervous System 7Ed;2006-07-28